Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Dec 16, 2024; 16(12): 668-677
Published online Dec 16, 2024. doi: 10.4253/wjge.v16.i12.668
Published online Dec 16, 2024. doi: 10.4253/wjge.v16.i12.668
Table 1 Baseline characteristics of eligible patients
Patient features | |
Number of patients | 202 |
Male, n (%) | 147 (72.8) |
Age (years), mean ± SD | 69.9 ± 10.1 |
BMI (kg/m2), mean ± SD | 23.7 ± 3.6 |
Specimen size (mm), mean ± SD | 31.7 ± 12.8 |
Tumor location, n (%) | |
Right colon | 81 (40.1) |
Left colon | 61 (30.2) |
Rectum | 60 (29.7) |
Tumor morphology, n (%) | |
0-Is/Ip | 88 (43.6) |
LST-G | 97 (48.0) |
LST-NG (0-IIc) | 17 (8.4) |
ECOG performance status after ESD, n (%) | |
0 | 194 (96.0) |
≥ 1 | 8 (4.0) |
Table 2 Clinicopathological factors in the post-endoscopic submucosal dissection electrocoagulation syndrome and non-post-endoscopic submucosal dissection electrocoagulation syndrome groups
PECS group, | Non-PECS group, | P value | OR (95%CI) | ||
Univariate analysis | Multivariate analysis | ||||
Sex, n (%) | 0.52 | ||||
Male | 21 (70.0) | 126 (73.3) | |||
Female | 9 (30.0) | 46 (26.7) | |||
Age, n (%) | 0.54 | ||||
< 75 years | 17 (56.7) | 112 (65.1) | |||
≥ 75 years | 13 (43.3) | 60 (34.9) | |||
Specimen size, n (%) | 0.24 | ||||
< 30 mm | 11 (36.7) | 83 (48.3) | |||
≥ 30 mm | 19 (63.3) | 89 (48.3) | |||
Tumor location, n (%) | 1.00 | ||||
Right colon | 12 (40.0) | 69 (40.1) | |||
Left colon | 10 (33.3) | 51 (29.7) | |||
Rectum | 8 (26.7) | 52 (30.2) | |||
Tumor morphology, n (%) | 0.85 | ||||
0-Is/Ip | 13 (43.3) | 75 (43.6) | |||
LST-G | 16 (53.4) | 81 (47.1) | |||
LST-NG (0-IIc) | 1 (3.3) | 16 (9.3) | |||
Depth of pathological invasion, n (%) | 0.54 | ||||
Tis (M) | 28 (93.4) | 152 (88.4) | |||
T1a (SM < 1000 μm) | 1 (3.3) | 11 (6.4) | |||
T1b (SM ≥ 1000 μm) | 1 (3.3) | 9 (5.2) | |||
Endoscopist, n (%) | 0.30 | ||||
Experts | 12 (40.0) | 54 (31.4) | |||
Trainees | 18 (60.0) | 118 (68.6) | |||
Submucosal fibrosis, n (%) | 0.30 | ||||
Present | 6 (20.0) | 27 (15.7) | |||
Absent | 24 (80.0) | 145 (84.3) | |||
ESD procedure time, n (%) | 0.18 | 0.16 | |||
< 90 minutes | 11 (36.7) | 91 (52.9) | 1 (reference) | ||
≥ 90 minutes | 19 (63.3) | 81 (47.1) | 1.76 (0.80-3.86) | ||
Total Joule heat, n (%) | < 0.01 | < 0.01 | |||
Low Joule heat | 4 (13.3) | 105 (61.0) | 1 (reference) | ||
High Joule heat | 26 (86.7) | 67 (39.0) | 7.96 (2.91-21.8) |
Table 3 Evaluation of the long procedure time group and short procedure time group
Long procedure time group (≥ 90 minutes), n = 100 | Short procedure time group (< 90 minutes), n = 102 | P value | |
Sex, n (%) | 0.75 | ||
Male | 73 (73.0) | 73 (71.6) | |
Female | 27 (27.0) | 29 (28.4) | |
Tumor location, n (%) | 0.67 | ||
Right colon | 42 (42.0) | 38 (37.3) | |
Left colon | 26 (26.0) | 35 (34.3) | |
Rectum | 32 (32.0) | 29 (28.4) | |
ESD procedure performed by trainees, n (%) | 73 (73.0) | 63 (61.8) | 0.10 |
Submucosal fibrosis, n (%) | 24 (24.0) | 9 (8.8) | < 0.01 |
PECS, n (%) | 19 (19.0) | 11 (10.8) | 0.33 |
Table 4 Cases of adverse events in the post-endoscopic submucosal dissection electrocoagulation syndrome and non-post-endoscopic submucosal dissection electrocoagulation syndrome groups
PECS group | Non-PECS group | |
Intraprocedural perforation or penetration/number of patients in each group | 1/30 | 5/172 |
ESD procedure performed by trainees/number of patients in each group | 1/30 | 5/172 |
Peak CRP (mg/dL), mean ± SD | 4.11 ± not applicable | 1.56 ± 1.42 |
Duration of hospitalization (days), mean ± SD | 6 ± not applicable | 6.2 ± 2.2 |
- Citation: Ochi M, Yamamoto A, Suematsu S, Fukuda K, Morishige K, Oka Y, Ishikawa Y, Ueyama S, Hiroshima Y, Omae Y, Kusano F, Kamoshida T. High Joule heat as a risk factor for post-endoscopic submucosal dissection electrocoagulation syndrome: A multicenter prospective study. World J Gastrointest Endosc 2024; 16(12): 668-677
- URL: https://www.wjgnet.com/1948-5190/full/v16/i12/668.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i12.668